bluebird bio (BLUE) Misses Q3 EPS by 56c

bluebird bio (NASDAQ: BLUE) reported Q3 EPS of ($3.16), $0.56 worse than the analyst estimate of ($2.60). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $35.4 million.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT